Our initial work suggests the first 20 days is a key window in the treatment period in which there may be a role for intervention strategies in patients predicted to be on a poor adherence trajectory. However, longer periods could now be studied for usage patterns and in relation to other factors that affect adherence, including personality types, side-effects and symptomatic improvements. The relationship between long-term treatment usage patterns and health outcomes is also important. This study is the first to combine objective OA treatment usage data and cluster analysis methods to identify patterns in the data. Understanding these individualized treatment patterns is an important step toward precision medicine in OSA and OA therapy.
Comments